Company Overview
Snapshot
Founded in December 2015 by Ido Savir and Shir Friedman, SuperMeat operates with 11–50 employees. The company has secured $14.5M across 8 funding rounds from 9 investors.
Business overview
SuperMeat is an Israeli food technology company focused on producing high-quality cultivated chicken meat directly from cells. The company's core technology involves a sustainable and animal-friendly process for growing meat, collaborating with pharmaceutical industry experts to ensure products are cost-efficient and delicious. SuperMeat primarily serves the agriculture and food technologies sector, targeting markets in the United States, Switzerland, and globally, with a focus on alternative proteins and sustainable food solutions for consumers, wholesale, and restaurants.
Strategic signal
SuperMeat's recent funding in May 2026, coupled with its strategic focus on the Swiss market, signals a strong push towards commercialization and international expansion for cultivated meat. This development indicates growing investor confidence in the viability and market readiness of cell-based protein alternatives, positioning SuperMeat as a key player in the evolving food industry landscape.
Company Intelligence Q&A
- What strategic partnership did SuperMeat announce in 2022?
- In July 2022, SuperMeat signed an agreement with Migros, Switzerland's largest supermarket and meat manufacturer, to advance its cultivated meat products.
- What was SuperMeat's earlier strategic partnership in the biotechnology sector?
- In March 2022, Ajinomoto, a leading food and biotechnology company, partnered with SuperMeat to collaborate on cellular agriculture.
- What was a key regulatory milestone for SuperMeat in 2023?
- In September 2023, SuperMeat's cultivated chicken became the first ever to receive US Kosher certification.